Please assess the completion status of the following clinical trial:

Trial Title: Oral Androgens in Man-4: (Short Title: Oral T-4)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE1/PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males between 18 to 55 years of age~* In good general health based on normal screening evaluation (consisting of a medical history, physical exam, normal serum chemistry, hematology, and baseline hormone levels)~* Subject must agree not to participate in another research drug study for the duration of the study~* Subject must agree to not donate blood during the study~* Subject must be willing to comply with the study protocol and procedures~Exclusion Criteria:~* Men in poor general health, with abnormal blood results (clinical laboratory tests or hormone values)~* A known history of alcohol or drug abuse~* A history of testicular disease or severe testicular trauma,~* A history of bleeding disorders or current use of anti-coagulants~* A history of sleep apnea and/or major psychiatric disorders~* A body-mass index greater than 35,~* A history of or current use of testosterone~* Infertility

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Oral Testosterone enanthate in sesame oil, 400 mg po (orally), BID (twice daily) + dutasteride 0.5 mg orally, qd (once daily) for 28 days + dutasteride load 24.5 mg po once
- 2 (Type: ACTIVE_COMPARATOR): Oral Testosterone sesame oil, 800 mg po (orally), qd (in am daily) + placebo sesame oil (in pm daily) + dutasteride 0.5 mg orally, qd (once daily) for 28 days + dutasteride load 24.5 mg po once

Based on this trial design, predict the completion outcome and termination type (if applicable).